Market Tracker

09/29 5:16pm ET

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

160.23
Delayed Data
As of 3:59pm ET
 -7.45 / -4.44%
Today’s Change
89.76
Today|||52-Week Range
217.99
+7.28%
Year-to-Date

Today’s Trading

Previous close167.68
Today’s open167.96
Day’s range159.82 - 168.69
Volume519,299
Average volume (3 months)488,569
Market cap$4.1B
Dividend yield--
Data as of 3:59pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)+29.86%
Earnings growth (this year)-69.26%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+59.74%
P/E ratioNM
Price/Sales1,272.01
Price/Book6.79

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.22-1.37%
ACADACADIA Pharmaceutica...-0.98-2.91%
AGNPRAAllergan plc-20.16-2.39%
PTHNPatheon NV+0.03+0.10%
Data as of 4:00pm ET, 09/29/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$3.83
Annual revenue (last year)$2.8M
Annual profit (last year)-$226.4M
Net profit margin-8,139.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer
Sandip Kapadia
Corporate headquarters
New York, New York

Forecasts